Strides Arcolab’s unit gets US FDA nod for oncology products; stock down

MUMBAI: Onco Therapies, a subsidiary of Strides Arcolab, has got US FDA approval for its oncology facility in Bangalore. The company is expecting to receive ANDA approvals for oncology products for which filings have already been made.

The stock was at Rs 380.95, down 1.12 per cent on the BSE. It touched a high of Rs 397.80 and low of Rs 375.30 in trade so far.